
Two MS Drug Candidates Show Promise Repairing Nerve Damage
After decades of failed attempts, Finnish researchers have identified two drug molecules that successfully trigger myelin repair in multiple sclerosis models. Both compounds crossed the blood-brain barrier and worked through entirely different mechanisms to achieve the same remarkable result.










